We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMMT icon
1551
Summit Therapeutics
SMMT
$9.88B
$2.65M 0.01%
622,866
+482,206
+343% +$877K
PK icon
1552
Park Hotels & Resorts
PK
$3.06B
$2.65M 0.01%
224,506
-45,540
-17% -$555K
MTUM icon
1553
iShares MSCI USA Momentum Factor ETF
MTUM
$24.3B
$2.64M 0.01%
+18,100
New +$2.63M
FTEV.WS
1554
CALL
DELISTED
FinTech Evolution Acquisition Group Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
FTEV.WS
$2.63M 0.01%
260,616
ZH
1555
Zhihu
ZH
$280M
$2.62M 0.01%
+336,388
New +$2.36M
LANV.WS
1556
CALL
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$2.61M 0.01%
+286,376
New +$75.1K
AGS
1557
DELISTED
PlayAGS
AGS
$2.61M 0.01%
512,002
+462,787
+940% +$2.61M
LION
1558
DELISTED
Lionheart III Corp Class A Common Stock
LION
$2.6M 0.01%
255,415
JGGC
1559
DELISTED
Jaguar Global Growth Corporation I Class A Ordinary Shares
JGGC
$2.6M 0.01%
254,318
RXO icon
1560
RXO
RXO
$3.72B
$2.6M 0.01%
+150,998
New +$2.68M
GFX.WS
1561
CALL
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$2.59M 0.01%
259,550
-163,227
-39% -$10.8K
IVCP
1562
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$2.59M 0.01%
255,751
MPRAW
1563
CALL
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$2.59M 0.01%
249,999
VMI icon
1564
Valmont Industries
VMI
$9.34B
$2.59M 0.01%
7,820
+362
+5% +$115K
CMCAW
1565
CALL
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$2.58M 0.01%
249,999
EL icon
1566
PUT
Estee Lauder
EL
$30.7B
$2.58M 0.01%
+10,400
New +$2.32M
PPYAW
1567
CALL
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$2.58M 0.01%
249,999
CARG icon
1568
CarGurus
CARG
$3.27B
$2.57M 0.01%
183,657
+169,557
+1,203% +$2.32M
CFFS
1569
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
$2.57M 0.01%
251,480
JGGCR
1570
CALL
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$2.56M 0.01%
249,996
VHAQ.WS
1571
CALL
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$2.55M 0.01%
239,823
ABPWW
1572
CALL
DELISTED
Abpro Holdings Warrant
ABPWW
$2.55M 0.01%
249,999
CUBI icon
1573
Customers Bancorp
CUBI
$2.67B
$2.55M 0.01%
89,819
-41,404
-32% -$1.29M
MBSC.WS
1574
CALL
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$2.53M 0.01%
249,996
WMG icon
1575
Warner Music
WMG
$14.9B
$2.53M 0.01%
+72,214
New +$2.11M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.